Avaris

Avaris Bio is a South San Francisco-based biotechnology company focused on the discovery and development of next-generation protein therapeutics. The company leverages a proprietary platform that integrates computational design with high-throughput screening to engineer biologics with enhanced therapeutic properties, such as improved stability, specificity, and potency. Avaris Bio's research efforts are primarily directed toward oncology and immunology, where they aim to address unmet medical needs through innovative molecular designs, including multi-specific and conditionally active molecules. By optimizing the pharmacological profiles of their candidates, Avaris Bio seeks to improve clinical outcomes and reduce systemic toxicities associated with traditional biologics.